Related Experiment Video
Updated: May 7, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Reasons for Nonattendance across the Hepatitis C Disease Course
Gail Butt1, Liza McGuinness, Terri Buller-Taylor
1UBC/BCCDC, 655 West 12th Avenue, Vancouver, BC, Canada V5Z 4R4.
Many factors influence hepatitis C (HCV) care nonattendance, starting at diagnosis. Improving integrated care, knowledge, and standardized follow-up can enhance patient attendance for HCV treatment.
Area of Science:
- Hepatology
- Public Health
- Qualitative Research
Background:
- Nonattendance for hepatitis C (HCV) care presents a significant barrier to effective disease management and treatment.
- Understanding the multifaceted reasons for patient nonattendance across the disease continuum is crucial for improving care engagement.
Purpose of the Study:
- To explore and describe patient, provider, and institutional factors contributing to nonattendance for hepatitis C (HCV) care.
- To identify themes related to nonattendance throughout the HCV disease course from multiple perspectives.
Main Methods:
- A descriptive qualitative study design was employed.
- Data were collected through interviews with 84 patients and health and social care providers.
- Thematic analysis was used to analyze the interview data.
Main Results:
- Six interrelated themes of nonattendance were identified: self-protection, determining benefits, competing priorities, knowledge gaps, access to services, and restrictive policies.
- Nonattendance patterns varied by disease stage, provider type, and patient context, often beginning at diagnosis due to lack of recommended follow-up.
- Factors promoting attendance included organized, low-barrier service access, nonjudgmental delivery, and higher patient/provider knowledge of HCV.
Conclusions:
- Nonattendance for HCV care is complex and influenced by various factors that change throughout the disease course.
- Missed opportunities exist for providers to encourage attendance, particularly at diagnosis.
- Interventions should focus on integrated health and social services, improved knowledge dissemination, and standardized liver disease monitoring protocols.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis II: Pathophysiology

